Search

Your search keyword '"Shah Neil"' showing total 4,017 results

Search Constraints

Start Over You searched for: Author "Shah Neil" Remove constraint Author: "Shah Neil"
4,017 results on '"Shah Neil"'

Search Results

101. Did We Get It Right? Predicting Query Performance in E-commerce Search

102. Semi-supervised Content-based Detection of Misinformation via Tensor Embeddings

103. False Information on Web and Social Media: A Survey

105. ATP-Competitive Inhibitors Midostaurin and Avapritinib Have Distinct Resistance Profiles in Exon 17–Mutant KIT

106. Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

107. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature

110. Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study

112. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

113. Metabolic Bone Disorders Are Predictors for 2-year Adverse Outcomes in Patients Undergoing 2–3 Level Anterior Cervical Discectomy and Fusion for Cervical Radiculopathy or Myelopathy

117. LookOut on Time-Evolving Graphs: Succinctly Explaining Anomalies from Any Detector

118. The Many Faces of Link Fraud

119. What Is the Epidemiology of Cervical and Thoracic Spine Fractures?

120. Epidemiology of Lumbar Spine Fractures: Twenty-Year Assessment of Nationwide Emergency Department Visit Data.

122. Injections of the Hand and Wrist: Part II. Carpal Tunnel Syndrome, Ganglion Cyst, Intersection Syndrome, Triangular Fibrocartilage Complex Injury, and de Quervain Tenosynovitis.

123. Injections of the Hand and Wrist: Part I. Trigger Finger, First Carpometacarpal Joint Osteoarthritis, and Palmar Fibromatosis.

124. Semi-supervised Multi-aspect Detection of Misinformation Using Hierarchical Joint Decomposition

125. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

126. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

128. Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

129. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

130. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

131. Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.

132. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

137. SAT-476 Development of a preference elicitation tool for treatment choice in unresectable, early/intermediate stage HCC

138. Patient-reported experience with an immunotherapy telehealth platform.

139. Assessing Feeding Difficulties in Children Presenting with Non-IgE-Mediated Gastrointestinal Food Allergies—A Commonly Reported Problem

141. Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial

142. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Catalog

Books, media, physical & digital resources